Q3 2025 · 13F-HR
Vitruvian Partners LLPholdings as filed
Filed 2025-11-10 · accession 0001420506-25-003049
$144.2M
Reported value
7
Positions
2025-09-30
Period end
The Brief · Vitruvian Partners LLP · Q3 2025
AI · grounded in 13F
Vitruvian Partners LLP established a new position in HINGE HEALTH INC HNGE valued at $61.35M. The fund also initiated stakes in MARQETA MQ for $36.18M and CARGURUS INC CARG for $17.61M. Additional new positions include XOMETRY INC XMTR, MAXCYTE MXCT, and GLOBAL-E GLBE. Total AUM for the fund stands at $144.19M across seven positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 433313103 | HNGE | HINGE HEALTH INC | $61.4M | 42.5% | 1,250,000 | Common | SOLE |
| 57142B104 | MQ | MARQETA | $36.2M | 25.1% | 6,853,183 | Common | SOLE |
| 141788109 | CARG | CARGURUS INC | $17.6M | 12.2% | 472,959 | Common | SOLE |
| 98423F109 | XMTR | XOMETRY INC | $12.8M | 8.90% | 235,660 | Common | SOLE |
| 57777K106 | MXCT | MAXCYTE | $8.0M | 5.53% | 5,043,356 | Common | SOLE |
| M5216V106 | GLBE | GLOBAL-E | $6.2M | 4.28% | 172,442 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT | $2.1M | 1.44% | 230,743 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.